Abstract
Mutations of the rpoB gene conferring resistance to rifampin were analyzed in 40 methicillin-resistant Staphylococcus aureus isolates obtained from six countries. Interestingly, the majority of clinical isolates showed multiple mutations within rpoB. The amino acid substitution 481His-->Asn was the most prevalent one, capable of conferring low-level resistance on its own. Cross-resistance to rifampin, rifabutin, and rifapentine was demonstrated for all mutants identified. The level of resistance to rifamycins correlated with both the mutation position and type of amino acid substitution.
MeSH Terms
Amino Acid Sequence
Anti-Bacterial Agents/pharmacology
DNA, Bacterial/analysis,genetics
DNA-Directed RNA Polymerases
Drug Resistance, Microbial
Electrophoresis, Polyacrylamide Gel
Escherichia coli/drug effects,genetics
Genotype
Humans
Methicillin Resistance/genetics
Microbial Sensitivity Tests
Molecular Sequence Data
Multigene Family/genetics
Plant Proteins/genetics
Rifamycins/pharmacology
Staphylococcal Infections/microbiology
Staphylococcus aureus/drug effects,genetics
Chemicals
Anti-Bacterial Agents
DNA, Bacterial
Plant Proteins
Rifamycins
RpoB protein, Oryza sativa
DNA-Directed RNA Polymerases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Wichelhaus T A
Institute of Medical Microbiology, University Hospital of Frankfurt, Frankfurt am Main, Germany.
Schäfer V
Brade V
Böddinghaus B
References (25)
25 references, click to expand
-
Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
J Antimicrob Chemother. 1998 Nov;42(5):621-8
PMID: 9848446
-
The rpoB gene of Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 1994 Apr;38(4):805-11
PMID: 8031050
-
Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis.
FEMS Microbiol Lett. 1996 Oct 15;144(1):103-8
PMID: 8870258
-
Nucleotide sequence of the Staphylococcus aureus RNA polymerase rpoB gene and comparison of its predicted amino acid sequence with those of other bacteria.
Biochim Biophys Acta. 1995 May 17;1262(1):73-8
PMID: 7772603
-
Methicillin-resistant Staphylococcus aureus in Europe.
Eur J Clin Microbiol Infect Dis. 1994 Jan;13(1):50-5
PMID: 8168564
-
Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.
J Mol Biol. 1988 Jul 5;202(1):45-58
PMID: 3050121
-
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.
Clin Microbiol Rev. 1997 Oct;10(4):781-91
PMID: 9336672
-
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.
Lancet. 1997 Jun 28;349(9069):1901-6
PMID: 9217771
-
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.
Lancet. 1993 Mar 13;341(8846):647-50
PMID: 8095569
-
Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis.
J Antimicrob Chemother. 1995 Feb;35(2):345-8
PMID: 7759399
-
RifR mutations in the beginning of the Escherichia coli rpoB gene.
Mol Gen Genet. 1994 Jul 25;244(2):120-6
PMID: 8052230
-
The beta subunit Rif-cluster I is only angstroms away from the active center of Escherichia coli RNA polymerase.
J Biol Chem. 1995 Dec 8;270(49):29428-32
PMID: 7493980
-
In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives.
Antimicrob Agents Chemother. 1994 May;38(5):1118-22
PMID: 8067748
-
The primary structure of Escherichia coli RNA polymerase. Nucleotide sequence of the rpoB gene and amino-acid sequence of the beta-subunit.
Eur J Biochem. 1981 Jun 1;116(3):621-9
PMID: 6266829
-
Genetic analysis of Staphylococcus aureus RNA polymerase mutants.
J Bacteriol. 1979 Jan;137(1):374-83
PMID: 33150
-
Clonal heterogeneity, distribution, and pathogenicity of methicillin-resistant Staphylococcus aureus.
Eur J Clin Microbiol Infect Dis. 1997 Dec;16(12):893-7
PMID: 9495669
-
Alternatives to vancomycin in treating methicillin-resistant Staphylococcus aureus infections.
J Antimicrob Chemother. 1998 Mar;41(3):325-8
PMID: 9578158
-
Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 1998 Jul;42(7):1853-7
PMID: 9661035
-
Molecular basis of rifampin resistance in Mycobacterium leprae.
Antimicrob Agents Chemother. 1993 Mar;37(3):414-8
PMID: 8460911
-
Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices?
Int J Antimicrob Agents. 1997 Jun;9(1):1-19
PMID: 18611815
-
Rifampin: mechanisms of action and resistance.
Rev Infect Dis. 1983 Jul-Aug;5 Suppl 3:S407-11
PMID: 6356275
-
Antimicrobial activity of rifabutin.
Clin Infect Dis. 1996 Apr;22 Suppl 1:S3-13; discussion S13-4
PMID: 8785253
-
Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus.
Antimicrob Agents Chemother. 1998 Oct;42(10):2590-4
PMID: 9756760
-
Molecular characterization of rifampin-resistant Neisseria meningitidis.
Antimicrob Agents Chemother. 1994 Jun;38(6):1256-61
PMID: 8092823
-
Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase.
J Biol Chem. 1993 Jul 15;268(20):14820-5
PMID: 8325861